Natpara Institutional Expansion Openings

Discussion in 'Shire' started by anonymous, Sep 13, 2016 at 5:57 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Salary? Bonus? Any information would be helpful. Hearing moral is not good in this division.
     

  2. anonymous

    anonymous Guest

    • During animal drug testing, NATPARA caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take NATPARA will have a higher chance of getting osteosarcoma. Tell your doctor right away if you have pain in any areas of your body that does not go away, or any new or unusual lumps or swelling under your skin that is tender to touch.
    • NATPARA is only available through the NATPARA Risk Evaluation and Mitigation Strategy (REMS) Program. The purpose of the NATPARA REMS Program is to inform patients about the potential risk of osteosarcoma associated with the use of NATPARA.
     
  3. anonymous

    anonymous Guest

    So if this drug causes cancer in mice, why in the heck would the FDA approve it?

    Salary is $130-$150K
     
  4. anonymous

    anonymous Guest

    Why the fuck is salary this high in other divisions, OBU didn't offers like this! That's bullshit!
     
  5. anonymous

    anonymous Guest

    I agree, the salary offers in the OBU aren't even close to that!
     
  6. anonymous

    anonymous Guest

    Tell me about it! That is unacceptable, WTF?!?
     
  7. anonymous

    anonymous Guest

    OBU is basically primary care. Don't like your salary, get promoted.
     
  8. anonymous

    anonymous Guest

    Primary care..whatever! I've sold in specialty I've sold buy and bill there's no difference.
     
  9. anonymous

    anonymous Guest

    Oh cmon, the obu is no better than a primary care job. It's a joke. These are institutional positions for an orphan drug. Stop comparing apples to oranges.
     
  10. anonymous

    anonymous Guest

    Like I said, I've sold buy and bill and I've worked institutions. Your job is not that difficult. You keep telling yourself it is to justify the fact you still don't work that much and make a ridiculous amount. You're still a drug rep.
     
  11. anonymous

    anonymous Guest

    Talked to recruiter this morning- they are looking for the best of the best and this is an elite salesforce. The drug hasn't been at expectations and this expansion is to bring new talent in. Salary 130k+ but very competitive to get job.
     
  12. anonymous

    anonymous Guest

    This job requires a lot of travel and they want the best reps available for this elite sales force. Why shouldn't Shire have to pay for the best?
     
  13. anonymous

    anonymous Guest

    Well it sounds like you made a terrible career decision then. Electing to take a primary care position over a more specialized role. Keep looking at the postings superstar. Maybe you can get "back in".
     
  14. anonymous

    anonymous Guest

    MOSTLY TRAVEL AND YOU WILL HAVE NO LIFE
     
  15. anonymous

    anonymous Guest

    yes, tons of travel, patients are starting to dry up, ship rates are brutal and you don't get paid now until it ships..which could take 3 months if it ever does. Bonus' were awesome,but mostly gone now, with the exception of a hand full of territories. Rare disease is not close to speciality sales...we're talking patient numbers of 30-50 total over multi state territories after 18 months....so hunting patients is the key.
     
  16. anonymous

    anonymous Guest

    OBU peeps have no idea how hard it is to sell Natpara, which isn't a true rare disease drug or salesforce by the way
     
  17. anonymous

    anonymous Guest

    They are only hiring a few so they can fire them fast. This drug is not sellable.
     
  18. anonymous

    anonymous Guest

    Please expand. Would appreciate your insight to the differences you see. I don't think this is a sellable drug the way they think it is.
     
  19. anonymous

    anonymous Guest

    There's no outcomes data. No long term renal benefits vs Ca and Vitamin D.

    Added to the osteosarcoma language in the label, the drug is dead in the water.

    The Marketing and Medical teams at NPS had a strategic plan in place but were shown the door once the acquisition by Shire was complete.
     
  20. anonymous

    anonymous Guest

    Did they decide to not hire for these positions?